Empagliflozin lowers serum uric acid in chronic kidney disease: exploratory analyses from the EMPA-KIDNEY trial

Mayne K., Sardell R., STAPLIN N., Judge P., ZHU D., SAMMONS E., EMBERSON J., PREISS D., LANDRAY M., BAIGENT C., HAYNES R., HERRINGTON W.

Type

Journal article

Journal

Nephrology Dialysis Transplantation

Publisher

Oxford University Press (OUP)

Publication Date

09/08/2024

Permalink